Journal Article

Thalamic atrophy measured by artificial intelligence in a multicentre clinical routine real-world study is associated with disability progression

Krug, Robert, Bagnato, Francesca, Hunter, Samuel, Singer, Barry, Smith, Andrew, Silva, Diego, Clarke, Margareta, Belkin, Martin, Smith, Derek, Wade, Peter, Edwards, Keith, Zivadinov, Robert, Cohan, Stanley, Dwyer, Michael G, Freedman, Mitch, Carpenter, Adam, Weinstock-Guttman, Bianca, Riolo, Jon, Singhal, Tarun, Benedict, Ralph H B, Gudesblatt, Mark, Bernitsas, Evanthia, Nicholas, Jaqueline, Nelson, Flavia, Jakimovski, Dejan, Pardo, Gabriel, Steingo, Brian, Jabour, Bradley, Repovic, Pavle, Feinberg, Marc, Zarif, Myassar, Silversteen, Jason, Baker, Matthew, Newman, Stephen, Zabad, Rana, Ruiz, Jennifer, Mazhari, Amir, Khatri, Bhupendra, Negroski, Donald, Bergsland, Niels

2022

Overview

BackgroundThe thalamus is a key grey matter structure, and sensitive marker of neurodegeneration in multiple sclerosis (MS). Previous reports indicated that thalamic volumetry using artificial intelligence (AI) on clinical-quality T2-fluid-attenuated inversion recovery (FLAIR) images alone is fast and reliable.ObjectiveTo investigate whether thalamic volume (TV) loss, measured longitudinally by AI, is associated with disability progression (DP) in patients with MS, participating in a large multicentre study.MethodsThe DeepGRAI (Deep Grey Rating via Artificial Intelligence) Registry is a multicentre (30 USA sites), longitudinal, observational, retrospective, real-world study of relapsing-remitting (RR) MS patients. Each centre enrolled between 30 and 35 patients. Brain MRI exams acquired at baseline and follow-up on 1.5T or 3T scanners with no prior standardisation were collected. TV measurement was performed on T2-FLAIR using DeepGRAI, and on two dimensional (D)-weighted and 3D T1-weighted images (WI) by using FMRIB’s Integrated Registration and Segmentation Tool software where possible.Results1002 RRMS patients were followed for an average of 2.6 years. Longitudinal TV analysis was more readily available on T2-FLAIR (96.1%), compared with 2D-T1-WI (61.8%) or 3D-T1-WI (33.2%). Over the follow-up, DeepGRAI TV loss was significantly higher in patients with DP, compared with those with disability improvement (DI) or disease stability (−1.35% in DP, −0.87% in DI and −0.57% in Stable, p=0.045, Bonferroni-adjusted, age-adjusted and follow-up time-adjusted analysis of covariance). In a regression model including MRI scanner change, age, sex, disease duration and follow-up time, DP was associated with DeepGRAI TV loss (p=0.022).ConclusionsThalamic atrophy measured by AI in a multicentre clinical routine real-world setting is associated with DP over mid-term follow-up.

• Publisher: BMJ Publishing Group Ltd,BMJ Publishing Group LTD
• Subject: Analysis of covariance / Artificial intelligence / Atrophy / Biomarkers / Brain research / Clinical medicine / CLINICAL NEUROLOGY / Clinical trials / Datasets / Multiple sclerosis / Neural networks / Pathology / Scanners / Software / Steroids